Sunnyvale, CA, United States of America

Dale Miles

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2005-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dale Miles - Innovator in Cancer Treatment

Introduction

Dale Miles is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of cancer treatment. With a total of three patents to his name, he has focused on developing innovative methods and compounds aimed at improving patient outcomes in oncology.

Latest Patents

One of Dale Miles' latest patents is titled "Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide." This patent describes a method for treating advanced renal cell carcinoma (RCC) in human patients who have previously undergone anti-angiogenic therapy using CABOMETYX, a kinase inhibitor. Another significant patent is "Texaphyrin coordination compounds and uses thereof," which discloses novel coordination polymers and their pharmaceutical formulations. These formulations are useful for treating atheroma, tumors, and other neoplastic tissues, as well as conditions responsive to targeted oxidative stress.

Career Highlights

Dale Miles has worked with prominent companies in the pharmaceutical industry, including Pharmacyclics, Inc. and Exelixis, Inc. His work has been instrumental in advancing therapeutic options for patients suffering from various forms of cancer.

Collaborations

Dale has collaborated with several professionals in his field, including Darren Magda and Nikolay Gerasimchuk, who have contributed to his research and development efforts.

Conclusion

Dale Miles is a dedicated inventor whose work in cancer treatment continues to impact the medical community positively. His innovative patents and collaborations highlight his commitment to improving patient care through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…